Sagittarius Life Science Corp

Sagittarius Life Science Corp

3205.TWO
Sagittarius Life Science CorpTW flagTaipei Exchange
52.20
TWD
-1.00
- -
3.53BMarket Cap

Total Valuation

Sagittarius Life Science Corp carries a market capitalization of 3.53B, placing it among publicly traded companies globally. Its enterprise value stands at 1.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.53B
Enterprise Value1.73B

Share Statistics

Sagittarius Life Science Corp currently has 67.55M shares outstanding.

Shares Outstanding67.55M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 7.31, and the price-to-book ratio stands at 4.04.

PE RatioN/A
PS Ratio7.31
PB Ratio4.04
P/TBV Ratio2.42
P/FCF Ratio-70.99
P/OCF Ratio-70.19

Enterprise Valuation

EV / Sales5.00
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Sagittarius Life Science Corp maintains a current ratio of 31.84, meaning it holds 31.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.04, indicating conservative leverage, while an interest coverage ratio of -860.35 demonstrates limited ability to service its debt obligations.

Current Ratio31.84
Quick Ratio30.92
Debt / Equity0.04
Debt / EBITDA-0.01
Interest Coverage-860.35

Financial Efficiency

Return on Equity (ROE)-10.98
Return on Assets (ROA)-6.23
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover14.41

Stock Price Statistics

Sagittarius Life Science Corp's stock has gained approximately 3.16206% over the past 52 weeks. The 50-day moving average sits at 54.28, while the 200-day moving average is 52.12.

Beta (5Y)N/A
52-Week Price Change3.16206%
50-Day Moving Average54.28
200-Day Moving Average52.12
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Sagittarius Life Science Corp generated 346.08M in revenue and converted that into -49.56M in net income, yielding earnings per share of -1.01. EBITDA reached -58.50M, while operating income came in at -58.50M.

Revenue346.08M
Gross Profit57.71M
Operating Income-58.50M
Pretax Income-49.87M
Net Income-49.56M
EBITDA-58.50M
EBIT-58.50M
Earnings Per Share (EPS)-1.01

Balance Sheet

Sagittarius Life Science Corp holds 803.55M in cash and equivalents against 385,000.00 in total debt, resulting in a net debt position of -151.55M. Total book value stands at 625.89M, with working capital of 801.46M providing operational flexibility.

Cash & Cash Equivalents803.55M
Total Debt385,000.00
Net Debt-151.55M
Equity (Book Value)625.89M
Book Value Per Share12.69
Working Capital801.46M

Cash Flow

Sagittarius Life Science Corp produced -36.05M in operating cash flow over the past twelve months. After subtracting -404,000.00 in capital expenditures, free cash flow totaled -36.45M - equivalent to -0.74 per share.

Operating Cash Flow-36.05M
Capital Expenditures-404,000.00
Free Cash Flow-36.45M
FCF Per Share-0.74

Margins

Sagittarius Life Science Corp operates with a gross margin of 16.68, reflecting its pricing power and cost economics. The operating margin of -16.90 and net profit margin of -14.32 provide insight into operational efficiency.

Gross Margin16.68
Operating Margin-16.90
Pretax Margin-14.41
Profit Margin-14.32
EBITDA Margin-16.90

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-26.20
FCF Yield-1.41

Stock Splits

Sagittarius Life Science Corp's most recent stock split took place on August 16, 2016 with a 1000:1057 split ratio.

Last Split Date8/16/2016
Split Ratio1000:1057

Scores

Sagittarius Life Science Corp posts an Altman Z-Score of 57.39, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score57.39